Frequent rapid COVID screenig is key and the Greater Toronto Airports Authority (GTAA) continued its leadership in supporting COVID-19 testing research today, when it announced a robust new COVID-19 PCR and antigen testing research program at Toronto Pearson. The program, which starts on March 1, is supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). It is designed to explore the efficacy of antigen testing, compared with the rapid polymerase chain reaction (PCR) test, in a high-throughput, commercial environment, as well as the operationalization of rapid PCR testing in an airport environment. TORONTO, Feb. 24, 2021
Frequent rapid COVID screening of asymptomatic people is an important layer among other essential public health measures to reduce the risk of spreading COVID-19. We are excited to be supporting the GTAA and their partners in evaluating rapid testing of employees to build on our current knowledge on how to safely and effectively implement these tools,” said Kevin Schwartz, infectious disease physician at Unity Health Toronto and the University of Toronto.